Results 201 to 210 of about 97,043 (300)
Polymorphic low-grade neuroepithelial tumor of the young and treatment of epilepsy: a case report. [PDF]
Li G +6 more
europepmc +1 more source
Abstract Objective Circulating small noncoding RNAs represent potential biomarkers of temporal lobe epilepsy (TLE). Recently, two transfer RNA fragments (tRFs), 5′tRF Glu‐CTC and Gly‐GCC, were found to be elevated in plasma samples collected in advance of a seizure in TLE patients, suggesting they may serve as potential wet biomarkers of seizure risk ...
Marie Soukupova +15 more
wiley +1 more source
The Top 100 Most Cited Articles on Epilepsy Surgery: A Bibliometric Analysis of the Literature. [PDF]
Gould J, Patel S, Chaurasia B.
europepmc +1 more source
Abstract Advances in stereo‐electroencephalography–guided radiofrequency thermocoagulation (SEEG‐guided RFTC) have led to the development of cross‐electrode RFTC, which has been shown to result in significantly larger lesions and higher seizure‐freedom rates compared to standard RFTC methods.
Bethany Campbell +10 more
wiley +1 more source
Ictal body turning and version in generalized epilepsy. [PDF]
Nagabushana D +3 more
europepmc +1 more source
Abstract Objective The International Classification of Cognitive Disorders in Epilepsy (IC‐CoDE) is a consensus‐based, empirically‐driven approach to standardize cognitive phenotyping in epilepsy research that has quickly garnered interest within the epilepsy community. However, manually generating IC‐CoDE phenotypes in group data is laborious and time‐
Robyn M. Busch +11 more
wiley +1 more source
Epilepsy in Patients with Cerebral Radiation Necrosis: A Scoping Review. [PDF]
Laman PVQ +5 more
europepmc +1 more source
Multinodular and vacuolating neuronal tumors in epilepsy: dysplasia or neoplasia? [PDF]
An S +17 more
core
Abstract Objective Sigma‐1 is a chaperone protein that serves as a key homeostatic regulator, implicated in neuronal excitability and seizure control. Positive allosteric modulators offer a use‐dependent means to enhance Sigma‐1 activity, potentially with favorable tolerability compared to direct agonists.
Eva‐Lotta von Rüden +5 more
wiley +1 more source

